封面
市場調查報告書
商品編碼
1356777

子宮內避孕器市場報告:2030 年趨勢、預測與競爭分析

Intrauterine Device Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

子宮內避孕器的趨勢和預測

預計到 2030 年,全球子宮內避孕器市場將達到約 47 億美元,2024 年至 2030 年年複合成長率為 4.1%。市場的主要促進因素是意外懷孕率的上升以及對長效可逆避孕藥的需求不斷成長。全球子宮內避孕器市場的未來前景廣闊,醫院、診所和社區健康中心市場充滿機會。

子宮內避孕器市場洞察

Lucintel 預測,荷爾蒙子宮內避孕器預計將在預測期內呈現最高成長,因為其高效能、​​非手術性質和適用性使其受到使用者的巨大需求。

由於預防性醫療就診人數的增加以及擁有現代化設備的改進醫院設施的可用性,預計醫院在預測期內將出現最高的成長。

由於人們對子宮內避孕器 (IUD) 的需求不斷成長、避孕意識不斷增強以及該地區主要企業的存在,預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2. 未來哪個細分市場成長較快?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要要素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些,由於材料或產品替代導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球子宮內避孕器市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球子宮內避孕器市場趨勢(2018-2023)與預測(2024-2030)
  • 全球子宮內避孕器市場(按產品)
    • 荷爾蒙子宮內避孕器
    • 非荷爾蒙子宮內避孕器
  • 按年齡層別分類的全球子宮內避孕器市場
    • 25-34歲
    • 35-44歲
    • 44歲以上
    • 15-24歲
  • 以最終用途的全球子宮內避孕器市場
    • 醫院
    • 診所
    • 區域醫療中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球子宮內避孕器市場區域分佈
  • 北美子宮內避孕器市場
  • 歐洲子宮內避孕器市場
  • 亞太地區子宮內避孕器市場
  • 其他區域子宮內避孕器市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球子宮內避孕器市場成長機會(按產品)
    • 按年齡層別分類的全球子宮內避孕器市場成長機會
    • 全球子宮內避孕器市場成長機會(依最終用途)
    • 按地區分類的全球子宮內避孕器市場成長機會
  • 全球子宮內避孕器市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球子宮內避孕器市場產能擴張
    • 全球子宮內避孕器市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Eurogine
  • Abviee
  • Mona Lisa
  • Pregna
  • Bayer
  • DKT International
  • CooperSurgical
  • Prosan
  • Viatris
簡介目錄

Intrauterine Device Trends and Forecast

The future of the global intrauterine device market looks promising with opportunities in the hospital, clinic, and community health care centre markets. The global intrauterine device market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are rising rates of unintended pregnancies and growing demand for long-acting reversible contraception.

A more than 150-page report is developed to help in your business decisions.

Intrauterine Device by Segment

The study includes a forecast for the global intrauterine device by product, age group, end use, and region.

Intrauterine Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Hormonal Intrauterine Devices
  • Non-Hormonal Intrauterine Devices

Intrauterine Device Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • 25-34 Years
  • 35-44 Years
  • Above 44 Years
  • 15-24 Years

Intrauterine Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Community Health Care Centres
  • Others

Intrauterine Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Intrauterine Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intrauterine device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intrauterine device companies profiled in this report include-

  • Eurogine
  • Abviee
  • Mona Lisa
  • Pregna
  • Bayer
  • DKT International
  • Coopersurgical
  • Prosan
  • Viatris

Intrauterine Device Market Insights

Lucintel forecasts that hormonal intrauterine device is expected to witness highest growth over the forecast period due to its significant demand among users give to its higher effectiveness, non-surgical nature, and suitability.

Hospital is expected to witness highest growth over the forecast perioddue to growing number of preventative healthcare visits and availability of improved hospital facilities with modernized devices in this setting.

North America is expected to witness highest growth over the forecast period due to growing demand for intrauterine device (IUD) among populations, rising awareness regarding birth control, and presence key players in the region.

Features of the Global Intrauterine Device Market

Market Size Estimates: Intrauterine device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intrauterine device market size by product, age group, end use, and region. in terms of value ($B).

Regional Analysis: Intrauterine device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, age groups, end uses, and region.s for the intrauterine device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intrauterine device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the intrauterine device market size?

Answer: The global intrauterine device market is expected to reach an estimated $4.7 billion by 2030.

Q.2. What is the growth forecast for intrauterine device market?

Answer: The global intrauterine device market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the intrauterine device market?

Answer: The major drivers for this market are rising rates of unintended pregnancies and growing demand for long-acting reversible contraception.

Q.4. What are the major segments for intrauterine device market?

Answer: The future of the intrauterine device market looks promising with opportunities in the hospital, clinic, and community health care centre markets.

Q.5. Who are the key intrauterine device market companies?

Answer: Some of the key intrauterine device companies are as follows:

  • Eurogine
  • Abviee
  • Mona Lisa
  • Pregna
  • Bayer
  • DKT International
  • CooperSurgical
  • Prosan
  • Viatris

Q.6. Which intrauterine device market segment will be the largest in future?

Answer: Lucintel forecasts that hormonal intrauterine device is expected to witness highest growth over the forecast period due to its significant demand among users give to its higher effectiveness, non-surgical nature, and suitability.

Q.7. In intrauterine device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing demand for intrauterine device (IUD) among populations, rising awareness regarding birth control, and presence key players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the intrauterine device market by product (hormonal intrauterine devices and non-hormonal intrauterine devices), age group (25-34 years, 35-44 years, above 44 years, and 15-24 years), end use (hospitals, clinics, community health care centres, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intrauterine Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Intrauterine Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Intrauterine Device Market by Product
    • 3.3.1: Hormonal Intrauterine Devices
    • 3.3.2: Non-Hormonal Intrauterine Devices
  • 3.4: Global Intrauterine Device Market by Age Group
    • 3.4.1: 25-34 Years
    • 3.4.2: 35-44 Years
    • 3.4.3: Above 44 Years
    • 3.4.4: 15-24 Years
  • 3.5: Global Intrauterine Device Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Community Health Care Centres
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Intrauterine Device Market by Region
  • 4.2: North American Intrauterine Device Market
    • 4.2.2: North American Intrauterine Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
  • 4.3: European Intrauterine Device Market
    • 4.3.1: European Intrauterine Device Market by Product: Hormonal Intrauterine Devices and Non-Hormonal Intrauterine Devices
    • 4.3.2: European Intrauterine Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
  • 4.4: APAC Intrauterine Device Market
    • 4.4.1: APAC Intrauterine Device Market by Product: Hormonal Intrauterine Devices and Non-Hormonal Intrauterine Devices
    • 4.4.2: APAC Intrauterine Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
  • 4.5: ROW Intrauterine Device Market
    • 4.5.1: ROW Intrauterine Device Market by Product: Hormonal Intrauterine Devices and Non-Hormonal Intrauterine Devices
    • 4.5.2: ROW Intrauterine Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Intrauterine Device Market by Product
    • 6.1.2: Growth Opportunities for the Global Intrauterine Device Market by Age Group
    • 6.1.3: Growth Opportunities for the Global Intrauterine Device Market by End Use
    • 6.1.4: Growth Opportunities for the Global Intrauterine Device Market by Region
  • 6.2: Emerging Trends in the Global Intrauterine Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Intrauterine Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intrauterine Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Eurogine
  • 7.2: Abviee
  • 7.3: Mona Lisa
  • 7.4: Pregna
  • 7.5: Bayer
  • 7.6: DKT International
  • 7.7: CooperSurgical
  • 7.8: Prosan
  • 7.9: Viatris